drugset / Trial / NCT07334080

ECC4703 Food Effect and Relative Bioavailability Study in Healthy Adult Participants

NCT07334080

Phase 1 Recruiting 72 enrolled Eccogene
RandomizedCrossoverOpen-labelTreatment

Summary

This is a Phase I, open-label, randomized, single-dose, 2-part study designed to evaluate the food effect and relative bioavailability of ECC4703 in healthy adult participants.

Timeline

Start
2026-01-10
Primary completion
2026-05
Completion
2026-05

Drugs

EvaluationDrugModalityDoseRoute
Subject ECC4703 Unknown